A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Novartis
Novartis
ImmVira Pharma Co. Ltd
Eli Lilly and Company
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Curis, Inc.
Shenzhen BinDeBio Ltd.
Mayo Clinic
Novartis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Valerio Therapeutics
University of Chicago
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Pediatric Brain Tumor Consortium